Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Artificial intelligence (A.I.) in dental curricula: Ethics and responsible integration.
Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
Post-translational modification by cysteine protects Cu/Zn-superoxide dismutase from oxidative damage.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
Sahu KK, Siddiqui AD, Cerny J. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside. Lab Med. 2021 Jan 04; 52(1):24-35.
View in:
PubMed
subject areas
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Critical Illness
Cytokines
Dendritic Cells
Disease Progression
Humans
Mesenchymal Stem Cell Transplantation
Severity of Illness Index
Survival Analysis
Treatment Outcome
authors with profiles
Jan Cerny MD, PhD